Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
This Therapeutic Goods Order constitutes a standard relating to the kinds of information required to be included on the label of prescription and other related medicines.
Recently published
This page was published on [date_placeholder].
Recently updated
This page was updated on [date_placeholder]. See page history for details.
Official version of legislation
The Federal Register of Legislation is the authorised Australian Government website for Commonwealth legislation. It contains the full text and details of the life cycle of individual laws.
Guidance referring to this legislation
-
GuidanceGuidelines for using the 'TGA assessed' claim on labels for assessed listed medicines and registered complementary medicines.
-
GuidanceThis guidance is to assist sponsors understand their requirements when supplying ‘unapproved’ therapeutic goods under the Special Access Scheme and Authorised Prescriber Pathway.
-
GuidanceGuidance to assist in meeting the Australian labelling requirements in TGO 91 and TGO 92.
-
GuidanceTips for sponsors, distributors and retailers on creating prescription medicine labels that are compliant with Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines (TGO 91).
-
GuidanceGuidance on mandatory warning statements for labels of medicines containing neuromuscular blocking agents.